CG
ABUS icon

Cutler Group’s Arbutus Biopharma ABUS Stock Holding History

Cutler Group’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-30,100
Closed -$5K – 5207
2021
Q4 		$5K Buy
+30,100
New +$117K ﹤0.01% 4137
2020
Q4 		– Sell
-17,300
Closed -$4K – 4716
2020
Q3 		$4K Buy
+17,300
New +$52.6K ﹤0.01% 3588
2019
Q2 		– Sell
-6,000
Closed -$3K – 4130
2019
Q1 		$3K Buy
+6,000
New +$23K ﹤0.01% 3139
2018
Q4 		– Sell
-8,000
Closed -$20K – 3840
2018
Q3 		$20K Buy
+8,000
New +$79.4K ﹤0.01% 2223

Other funds holding ABUS

WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return